HEADER CELL ADHESION 03-APR-12 4EHP TITLE CRYSTAL STRUCTURE OF HUMAN VINCULIN HEAD DOMAIN (RESIDUES 1-252) IN TITLE 2 COMPLEX WITH ALPHA-CATENIN (RESIDUES 277-382) COMPND MOL_ID: 1; COMPND 2 MOLECULE: VINCULIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 1-252; COMPND 5 SYNONYM: METAVINCULIN; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: CATENIN ALPHA-1; COMPND 9 CHAIN: B; COMPND 10 FRAGMENT: UNP RESIDUES 277-382; COMPND 11 SYNONYM: ALPHA E-CATENIN, CADHERIN-ASSOCIATED PROTEIN, RENAL COMPND 12 CARCINOMA ANTIGEN NY-REN-13; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: VCL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET24; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: CTNNA1; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PGEX-6P-1 KEYWDS ADHERENS JUNCTIONS, VINCULIN BINDING SITE, VINCULIN BINDING DOMAIN, KEYWDS 2 HELIX BUNDLE, CELL ADHESION EXPDTA X-RAY DIFFRACTION AUTHOR T.IZARD,E.S.RANGARAJAN REVDAT 3 13-SEP-23 4EHP 1 REMARK SEQADV REVDAT 2 17-JUL-13 4EHP 1 JRNL REVDAT 1 18-APR-12 4EHP 0 JRNL AUTH E.S.RANGARAJAN,T.IZARD JRNL TITL ALPHA-CATENIN UNFURLS UPON BINDING TO VINCULIN JRNL REF J.BIOL.CHEM. V. 287 18492 2012 JRNL REFN ISSN 0021-9258 JRNL PMID 22493458 JRNL DOI 10.1074/JBC.M112.351023 REMARK 2 REMARK 2 RESOLUTION. 2.66 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.66 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 22.71 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 13637 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.194 REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.030 REMARK 3 FREE R VALUE TEST SET COUNT : 686 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 7 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.66 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.87 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2754 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2071 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2580 REMARK 3 BIN R VALUE (WORKING SET) : 0.2023 REMARK 3 BIN FREE R VALUE : 0.2792 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 6.32 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 174 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2672 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 36 REMARK 3 SOLVENT ATOMS : 82 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 58.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 60.09 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -12.47800 REMARK 3 B22 (A**2) : 6.13460 REMARK 3 B33 (A**2) : 6.34350 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.312 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.545 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.936 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.916 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 1347 ; 2.000 ; SINUSOIDAL REMARK 3 BOND ANGLES : NULL ; NULL ; NULL REMARK 3 TORSION ANGLES : 80 ; 2.000 ; HARMONIC REMARK 3 TRIGONAL CARBON PLANES : 376 ; 5.000 ; SEMIHARMONIC REMARK 3 GENERAL PLANES : 1 ; 1.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : NULL ; NULL ; NULL REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : NULL ; NULL ; NULL REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : NULL ; NULL ; NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.36 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 3.32 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4EHP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-APR-12. REMARK 100 THE DEPOSITION ID IS D_1000071631. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-OCT-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : SAGITALLY FOCUSED SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XSCALE REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.16, XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13785 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.655 REMARK 200 RESOLUTION RANGE LOW (A) : 107.432 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.200 REMARK 200 R MERGE (I) : 0.08900 REMARK 200 R SYM (I) : 0.06800 REMARK 200 FOR THE DATA SET : 21.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.30 REMARK 200 R MERGE FOR SHELL (I) : 0.48500 REMARK 200 R SYM FOR SHELL (I) : 0.48500 REMARK 200 FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2IBF REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.85 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.79 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, SODIUM ACETATE, VAPOR REMARK 280 DIFFUSION, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 28.62500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.98000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.62500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.98000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL UNIT COULD BE EITHER REMARK 300 A HETERODIMER OR A TETRAMER IN SOLUTION. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6250 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19600 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -41.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 MET A 1 REMARK 465 ASN A 220 REMARK 465 GLN A 221 REMARK 465 GLY A 222 REMARK 465 GLY B 272 REMARK 465 PRO B 273 REMARK 465 LEU B 274 REMARK 465 GLY B 275 REMARK 465 SER B 276 REMARK 465 GLU B 277 REMARK 465 LEU B 278 REMARK 465 ALA B 279 REMARK 465 TYR B 280 REMARK 465 ALA B 281 REMARK 465 LEU B 282 REMARK 465 ASN B 283 REMARK 465 ASN B 284 REMARK 465 PHE B 285 REMARK 465 ASP B 286 REMARK 465 LYS B 287 REMARK 465 GLN B 288 REMARK 465 ILE B 289 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 CYS B 324 CB REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 151 107.10 -54.91 REMARK 500 GLN B 381 40.92 72.66 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 305 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 306 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 307 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 308 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 309 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1TR2 RELATED DB: PDB REMARK 900 RELATED ID: 1RKE RELATED DB: PDB REMARK 900 RELATED ID: 4DJ9 RELATED DB: PDB REMARK 900 RELATED ID: 3TJ5 RELATED DB: PDB REMARK 900 RELATED ID: 1SYQ RELATED DB: PDB REMARK 900 RELATED ID: 1RKC RELATED DB: PDB REMARK 900 RELATED ID: 2GWW RELATED DB: PDB REMARK 900 RELATED ID: 3RF3 RELATED DB: PDB REMARK 900 RELATED ID: 3S90 RELATED DB: PDB REMARK 900 RELATED ID: 3TJ6 RELATED DB: PDB REMARK 900 RELATED ID: 2HSQ RELATED DB: PDB REMARK 900 RELATED ID: 2IBF RELATED DB: PDB REMARK 900 RELATED ID: 1YDI RELATED DB: PDB REMARK 900 RELATED ID: 3H2U RELATED DB: PDB REMARK 900 RELATED ID: 3H2V RELATED DB: PDB REMARK 900 RELATED ID: 3MYI RELATED DB: PDB REMARK 900 RELATED ID: 3SMZ RELATED DB: PDB DBREF 4EHP A 1 252 UNP P18206 VINC_HUMAN 1 252 DBREF 4EHP B 277 382 UNP P35221 CTNA1_HUMAN 277 382 SEQADV 4EHP MET A 0 UNP P18206 INITIATING METHIONINE SEQADV 4EHP GLY B 272 UNP P35221 EXPRESSION TAG SEQADV 4EHP PRO B 273 UNP P35221 EXPRESSION TAG SEQADV 4EHP LEU B 274 UNP P35221 EXPRESSION TAG SEQADV 4EHP GLY B 275 UNP P35221 EXPRESSION TAG SEQADV 4EHP SER B 276 UNP P35221 EXPRESSION TAG SEQRES 1 A 253 MET MET PRO VAL PHE HIS THR ARG THR ILE GLU SER ILE SEQRES 2 A 253 LEU GLU PRO VAL ALA GLN GLN ILE SER HIS LEU VAL ILE SEQRES 3 A 253 MET HIS GLU GLU GLY GLU VAL ASP GLY LYS ALA ILE PRO SEQRES 4 A 253 ASP LEU THR ALA PRO VAL ALA ALA VAL GLN ALA ALA VAL SEQRES 5 A 253 SER ASN LEU VAL ARG VAL GLY LYS GLU THR VAL GLN THR SEQRES 6 A 253 THR GLU ASP GLN ILE LEU LYS ARG ASP MET PRO PRO ALA SEQRES 7 A 253 PHE ILE LYS VAL GLU ASN ALA CYS THR LYS LEU VAL GLN SEQRES 8 A 253 ALA ALA GLN MET LEU GLN SER ASP PRO TYR SER VAL PRO SEQRES 9 A 253 ALA ARG ASP TYR LEU ILE ASP GLY SER ARG GLY ILE LEU SEQRES 10 A 253 SER GLY THR SER ASP LEU LEU LEU THR PHE ASP GLU ALA SEQRES 11 A 253 GLU VAL ARG LYS ILE ILE ARG VAL CYS LYS GLY ILE LEU SEQRES 12 A 253 GLU TYR LEU THR VAL ALA GLU VAL VAL GLU THR MET GLU SEQRES 13 A 253 ASP LEU VAL THR TYR THR LYS ASN LEU GLY PRO GLY MET SEQRES 14 A 253 THR LYS MET ALA LYS MET ILE ASP GLU ARG GLN GLN GLU SEQRES 15 A 253 LEU THR HIS GLN GLU HIS ARG VAL MET LEU VAL ASN SER SEQRES 16 A 253 MET ASN THR VAL LYS GLU LEU LEU PRO VAL LEU ILE SER SEQRES 17 A 253 ALA MET LYS ILE PHE VAL THR THR LYS ASN SER LYS ASN SEQRES 18 A 253 GLN GLY ILE GLU GLU ALA LEU LYS ASN ARG ASN PHE THR SEQRES 19 A 253 VAL GLU LYS MET SER ALA GLU ILE ASN GLU ILE ILE ARG SEQRES 20 A 253 VAL LEU GLN LEU THR SER SEQRES 1 B 111 GLY PRO LEU GLY SER GLU LEU ALA TYR ALA LEU ASN ASN SEQRES 2 B 111 PHE ASP LYS GLN ILE ILE VAL ASP PRO LEU SER PHE SER SEQRES 3 B 111 GLU GLU ARG PHE ARG PRO SER LEU GLU GLU ARG LEU GLU SEQRES 4 B 111 SER ILE ILE SER GLY ALA ALA LEU MET ALA ASP SER SER SEQRES 5 B 111 CYS THR ARG ASP ASP ARG ARG GLU ARG ILE VAL ALA GLU SEQRES 6 B 111 CYS ASN ALA VAL ARG GLN ALA LEU GLN ASP LEU LEU SER SEQRES 7 B 111 GLU TYR MET GLY ASN ALA GLY ARG LYS GLU ARG SER ASP SEQRES 8 B 111 ALA LEU ASN SER ALA ILE ASP LYS MET THR LYS LYS THR SEQRES 9 B 111 ARG ASP LEU ARG ARG GLN LEU HET ACT A 301 4 HET ACT A 302 4 HET ACT A 303 4 HET ACT A 304 4 HET ACT A 305 4 HET ACT A 306 4 HET ACT A 307 4 HET ACT A 308 4 HET ACT A 309 4 HETNAM ACT ACETATE ION FORMUL 3 ACT 9(C2 H3 O2 1-) FORMUL 12 HOH *82(H2 O) HELIX 1 1 THR A 6 GLU A 29 1 24 HELIX 2 2 LEU A 40 THR A 65 1 26 HELIX 3 3 ASP A 67 MET A 74 1 8 HELIX 4 4 MET A 74 ASP A 98 1 25 HELIX 5 5 VAL A 102 THR A 146 1 45 HELIX 6 6 THR A 153 ASN A 163 1 11 HELIX 7 7 LEU A 164 LEU A 182 1 19 HELIX 8 8 HIS A 184 SER A 218 1 35 HELIX 9 9 GLU A 224 GLN A 249 1 26 HELIX 10 10 ASP B 292 ARG B 300 1 9 HELIX 11 11 SER B 304 ALA B 317 1 14 HELIX 12 12 CYS B 324 ARG B 326 5 3 HELIX 13 13 ASP B 327 GLY B 353 1 27 HELIX 14 14 ASN B 354 GLY B 356 5 3 HELIX 15 15 ASP B 362 GLN B 381 1 20 SSBOND 1 CYS B 324 CYS B 324 1555 2545 2.03 SITE 1 AC1 5 THR A 6 ILE A 9 ASP A 127 HOH A 447 SITE 2 AC1 5 ARG B 330 SITE 1 AC2 4 ASP A 39 LEU A 250 THR A 251 SER A 252 SITE 1 AC3 3 ILE A 245 GLN A 249 HOH A 454 SITE 1 AC4 3 SER A 207 LYS A 228 ASN A 229 SITE 1 AC5 6 VAL A 32 LYS A 35 TYR A 100 SER A 101 SITE 2 AC5 6 ARG A 105 TYR B 351 SITE 1 AC6 2 THR A 197 GLU A 200 SITE 1 AC7 4 THR A 65 PHE A 126 LYS A 133 ARG B 329 SITE 1 AC8 2 LYS A 87 ASP A 110 SITE 1 AC9 6 PRO A 2 GLN A 90 TYR A 107 THR A 183 SITE 2 AC9 6 GLN A 185 GLU A 186 CRYST1 57.250 73.960 107.430 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017467 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013521 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009308 0.00000